Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2017-08-10Clinical Trial Update: Next-generation Sequencing of Small Cell Lung Cancer to Identify Susceptibility Gene and to Assess Treatment
A clinical trial update outlining the use of next-generation sequencing in small cell lung cancer to identify a susceptibility gene and to a…
-
CLINICAL_TRIALS research · 2017-07-26Clinical Trial Update: Study of Nab-paclitaxel in Sensitive and Refractory Relapsed SCLC [Phase 2]
Phase 2 clinical trial evaluating nab-paclitaxel in patients with sensitive and refractory relapsed small cell lung cancer.
-
CLINICAL_TRIALS research · 2017-04-04Clinical Trial Update: Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC
A retrospective, multi-indication study sponsored by Optimata Ltd. to validate PrediCare's ability to predict Time To Progression in cancer …
-
CLINICAL_TRIALS research · 2017-01-10Clinical Trial Update: Circulating Tumor Cells (CTCs) as a Blood-based Tumor Marker in Patients With Small Cell Lung Cancer (SCLC)
An update on a completed clinical trial evaluating circulating tumor cells as a blood-based biomarker in patients with small cell lung cance…
-
CLINICAL_TRIALS research · 2016-12-05Clinical Trial Update: Irinotecan Plus Cisplatin Compared With Etoposide Plus Cisplatin for Extensive Stage Small-cell Lung Cancer [Phase 4]
A Phase 4 clinical trial update comparing Irinotecan plus Cisplatin with Etoposide plus Cisplatin for extensive-stage small cell lung cancer…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-10-10Clinical Trial Update: Memory and MRI Changes With Hippocampus Avoidance Prophylactic Cranial Irradiation(HA-PCI) for Small Cell Lung Cancer(SCLC) [Phase 2]
Phase 2 clinical trial update evaluating memory outcomes and MRI changes with hippocampus-avoidance prophylactic cranial irradiation in smal…
-
CLINICAL_TRIALS research · 2016-08-24Clinical Trial Update: Apatinib as the Maintenance Therapy for Extensive Stage Small Cell Lung Cancer After Combined With Etoposide/Cisplatin [Phase 3]
Phase 3 clinical trial evaluating apatinib as maintenance therapy after etoposide/cisplatin in extensive-stage small cell lung cancer; curre…
-
CLINICAL_TRIALS research · 2016-06-10Clinical Trial Update: Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment [NA]
An ongoing clinical trial is exploring markers of primary or acquired resistance to anticancer therapies in melanoma and lung cancers; curre…
-
CLINICAL_TRIALS research · 2016-05-17Clinical Trial Update: Clinical Randomized Study of Concurrent Chemo-radiotherapy vs Radiotherapy Alone to Local-advanced Small Cell Lung Cancer (SCLC) [Phase 2]
This is a Phase 2 randomized study comparing concurrent chemoradiotherapy versus radiotherapy alone for locally advanced small cell lung can…
-
CLINICAL_TRIALS research · 2016-04-14Clinical Trial Update: SBRT Compared With IMRT Concurrently With Chemotherapy in Treating Patients With LS-SCLC [Phase 2]
Phase II trial update comparing SBRT versus IMRT given with chemotherapy for limited-stage small cell lung cancer; no results are provided i…
-
CLINICAL_TRIALS research · 2016-04-13Clinical Trial Update: HS-WBRT for Prophylactic Cranial Irradiation in Limited Stage Small Cell Lung Cancer [NA]
This clinical trial update describes HS-WBRT for prophylactic cranial irradiation in limited-stage small cell lung cancer, with the trial st…
-
CLINICAL_TRIALS research · 2016-02-10Clinical Trial Update: A Phase Ib/II Trial of Belotecan and Ifosfamide in Patients With Extensive Disease of Small Cell Lung Cancer [Phase 1, Phase 2]
A Phase Ib/II trial evaluating belotecan in combination with ifosfamide for extensive-disease small cell lung cancer; the study status is no…
-
CLINICAL_TRIALS research · 2016-01-26Clinical Trial Update: Temozolomide as Maintenance Therapy in Small Cell Lung Cancer [Phase 2]
Phase 2 study evaluating temozolomide as maintenance therapy in small cell lung cancer; the update provides no results in the snippet.
-
CLINICAL_TRIALS research · 2016-01-26Clinical Trial Update: Topotecan and Cisplatin Versus Etoposide and Carboplatin in 1st Line Treatment of Patients With Small Cell Lung Cancer and Extensive Disease (SCLC-ED) [Phase 3]
Phase 3 trial comparing Topotecan plus Cisplatin to Etoposide plus Carboplatin in first-line extensive-disease small cell lung cancer; the s…
-
CLINICAL_TRIALS research · 2014-12-02Clinical Trial Update: Belotecan and Cisplatin in Treating Patients With Previously Untreated, Extensive-Stage Small Cell Lung Cancer [Phase 2]
This clinical trial update reports on a Phase 2 study of belotecan in combination with cisplatin for previously untreated, extensive-stage s…
-
CLINICAL_TRIALS research · 2014-11-05Clinical Trial Update: Value of Physical Capacity Tests in Lung Cancer
A completed clinical trial evaluating the value of physical capacity tests in patients with lung cancer (non-small cell and small cell).
-
CLINICAL_TRIALS research · 2014-03-31Clinical Trial Update: Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer [Phase 1]
Phase 1 trial evaluating vaccine therapy with or without sargramostim and with or without docetaxel in patients with metastatic lung cancer …
-
CLINICAL_TRIALS research · 2014-01-17Clinical Trial Update: Study of Gemcitabine Maintenance Treatment in Patients With Extensive SCLC Patients [Phase 2]
Phase 2 clinical trial evaluating gemcitabine as maintenance therapy in patients with extensive small cell lung cancer. The current status i…
-
CLINICAL_TRIALS research · 2013-06-18Clinical Trial Update: A Clinical Study of Liposomal Doxorubicin Combined With Ifosfamide Second-line Treatment in Small Cell Lung Cancer [Phase 2]
This document provides an update on a Phase 2 clinical study evaluating liposomal doxorubicin in combination with ifosfamide as second-line …
-
CLINICAL_TRIALS research · 2013-01-23Clinical Trial Update: A Prospective Randomized Study Comparing the Target Volume for Limited-stage Small Cell Lung Cancer [Phase 2, Phase 3]
A prospective randomized study comparing target volume for limited-stage small cell lung cancer, spanning Phase 2 and Phase 3.
-
CLINICAL_TRIALS research · 2012-07-18Clinical Trial Update: Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies [Phase 1]
Phase 1 trial evaluating intravenous palifosfamide-tris in combination with etoposide and carboplatin in patients with various malignancies;…
-
CLINICAL_TRIALS research · 2012-07-03Clinical Trial Update: Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial update evaluating maintenance therapy with autologous cytokine-induced killer cells for small cell lung cancer.
-
CLINICAL_TRIALS research · 2012-06-13Clinical Trial Update: S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung Cancer [Phase 2]
This clinical trial update notes that the Phase 2 SWOG trial combining chemotherapy, radiation therapy, and vaccine therapy for limited-stag…
-
CLINICAL_TRIALS research · 2011-09-07Clinical Trial Update: A Prospective Study of Variation in Breath Holding Times at Various Phases of Respiration During the Course of Radiotherapy Including the Effect of Respiratory Training in Lung Cancer Patients [Phase 2]
This is a Phase 2 prospective study evaluating variation in breath-holding times during radiotherapy in lung cancer patients and the impact …
-
CLINICAL_TRIALS research · 2011-03-03Clinical Trial Update: Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors [Phase 2]
Phase 2 trial investigating hyperthermia/thermal therapy with chemotherapy for inoperable or metastatic tumors. The listed conditions includ…